Evidence map›Paper›PMID 27552541›Full record

ArticleThe Journal of clinical endocrinology and metabolism2016

Bone Mineral Density and Progression of Subclinical Atherosclerosis in African-Americans With Type 2 Diabetes.

Lynne E Wagenknecht, Jasmin Divers, Thomas C Register, Gregory B Russell, Donald W Bowden, Jianzhao Xu, Carl D Langefeld, Leon Lenchik, Keith A Hruska, J Jeffrey Carr and 1 more

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. FGF23 Concentration andDiabetes care · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lynne E WagenknechtDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Jasmin DiversDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Thomas C RegisterDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Gregory B RussellDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Donald W BowdenDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Jianzhao XuDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Carl D LangefeldDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Leon LenchikDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Keith A HruskaDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
J Jeffrey CarrDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Barry I FreedmanDivision of Public Health Sciences (L.E.W., J.D., G.B.R., C.D.L.), Department of Pathology (T.C.R.), Department of Biochemistry (D.W.B., J.X.), and Department of Radiology (L.L.), Wake Forest School of Medicine, Winston-Salem, North Carolina; Division of Pediatric Nephrology (K.A.H.), Washington University School of Medicine, St. Louis, Missouri; Department of Radiology (J.J.C.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Internal Medicine (B.I.F.), Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Funding

Subclinical CVD in African American Type 2 DiabeticsR01DK071891 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2007 to 2016
$4.5M
Epidemiology of cardiovascular disease in diabetesR01HL067348 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BOWDEN, DONALD W · 2001 to 2004
$4.3M
Genetics of Bone and Vascular Calcium in Type 2 DiabetesR01AR048797 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CARR, JOHN JEFFREY · 2001 to 2004
$1.3M
NHLBI NIH HHS R01 HL067348NIAMS NIH HHS R01 AR048797NIDDK NIH HHS R01 DK071891
6 · The paper itself

Abstract

contextRelative to European Americans, calcified atherosclerotic plaque (CP) is less prevalent and severe in African-Americans (AAs).

objectivePredictors of progression of CP in the aorta, carotid, and coronary arteries were examined in AAs over a mean 5.3 ± 1.4-year interval.

designThis is the African American-Diabetes Heart Study.

settingA type 2 diabetes (T2D)-affected cohort was included.

participantsA total of 300 unrelated AAs with T2D; 50% female, mean age 55 ± 9 years, baseline hemoglobin A1c 8.1 ± 1.8% was included.

main outcome measuresGlycemic control, renal parameters, vitamin D, and computed tomography-derived measures of adiposity, vascular CP, and volumetric bone mineral density (vBMD) in lumbar and thoracic vertebrae were obtained at baseline and follow-up.

resultsCP increased in incidence and quantity/mass in all three vascular beds over the 5-year study (P < .0001). Lower baseline lumbar and thoracic vBMD were associated with progression of abdominal aorta CP (P < .008), but not progression of carotid or coronary artery CP. Lower baseline estimated glomerular filtration rate was associated with progression of carotid artery CP (P = .0004), and higher baseline pericardial adipose volume was associated with progression of coronary artery (P = .001) and aorta (P = .0006) CP independent of body mass index. There was a trend for an inverse relationship between change in thoracic vBMD and change in aortic CP (P = .05).

conclusionsIn this longitudinal study, lower baseline thoracic and lumbar vBMD and estimated glomerular filtration rate and higher pericardial adipose volumes were associated with increases in CP in AAs with T2D. Changes in these variables and baseline levels and/or changes in glycemic control, albuminuria, and vitamin D were not significantly associated with progression of CP.

Indexed as

Bone DensityDisease ProgressionAdipose TissueAortic DiseasesAtherosclerosisBlack or African AmericanCalcinosisCarotid Artery DiseasesComorbidityCoronary VesselsDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedPlaque, Atherosclerotic

Identifiers

PMID27552541
PMCPMC5095232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.